ZYC00101: Began Phase I/II testing

Zycos Inc., Cambridge, Mass. Product: ZYC00101 Business: Cancer Therapeutic category: Viral infection, Immune stimulation Target: Immune cells Description: DNA-based vaccine against human papillomavir...